PROCEPT BioRobotics Corporation
PRCT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $4,197 | $1,980 | $1,844 | $1,092 |
| - Cash | $334 | $257 | $222 | $304 |
| + Debt | $80 | $79 | $77 | $54 |
| Enterprise Value | $3,944 | $1,802 | $1,700 | $842 |
| Revenue | $224 | $136 | $75 | $34 |
| % Growth | 64.8% | 81.6% | 117.6% | – |
| Gross Profit | $137 | $71 | $37 | $16 |
| % Margin | 61.1% | 52.2% | 49.4% | 46% |
| EBITDA | -$82 | -$98 | -$79 | -$51 |
| % Margin | -36.5% | -72% | -105.5% | -147.1% |
| Net Income | -$91 | -$106 | -$87 | -$60 |
| % Margin | -40.7% | -77.8% | -116.2% | -173.6% |
| EPS Diluted | -1.75 | -2.24 | -1.96 | -3.63 |
| % Growth | 21.9% | -14.3% | 46% | – |
| Operating Cash Flow | -$99 | -$108 | -$80 | -$57 |
| Capital Expenditures | -$4 | -$25 | -$3 | -$1 |
| Free Cash Flow | -$104 | -$133 | -$83 | -$58 |